Published in Mayo Clin Proc on October 01, 1991
Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome. Antimicrob Agents Chemother (1994) 0.86
Interethnic differences of PEPT2 (SLC15A2) polymorphism distribution and associations with cephalexin pharmacokinetics in healthy Asian subjects. Eur J Clin Pharmacol (2008) 0.82
Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis (1998) 3.96
Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc (1997) 2.62
Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis (2006) 2.53
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52
Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. J Infect Dis (1995) 2.37
Early and late survival after surgical treatment of culture-positive active endocarditis. Mayo Clin Proc (1995) 2.17
Staphylococcus lugdunensis endocarditis: a complication of vasectomy? Mayo Clin Proc (1999) 2.17
Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis (1997) 2.04
Infective endocarditis caused by HACEK microorganisms. Annu Rev Med (1997) 2.03
Determination of 16S rRNA sequences of enterococci and application to species identification of nonmotile Enterococcus gallinarum isolates. J Clin Microbiol (1998) 2.02
DNA sequence variation within vanA, vanB, vanC-1, and vanC-2/3 genes of clinical Enterococcus isolates. Antimicrob Agents Chemother (1998) 1.79
Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experience. J Clin Microbiol (2000) 1.65
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis (1996) 1.63
Bacteremia due to Enterococcus avium. Clin Infect Dis (1993) 1.57
Xanthomonas maltophilia: an emerging nosocomial pathogen. Mayo Clin Proc (1989) 1.51
Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis (1996) 1.46
Artificial Valve Endocarditis Reduction Trial (AVERT): protocol of a multicenter randomized trial. J Heart Valve Dis (1999) 1.42
Follow-up MR imaging in patients with pyogenic spine infections: lack of correlation with clinical features. AJNR Am J Neuroradiol (2007) 1.42
In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis (1999) 1.36
Urinary tract infection caused by nontyphoidal Salmonella: report of 30 cases. Urol Int (1992) 1.33
Linezolid therapy of Staphylococcus aureus experimental osteomyelitis. Antimicrob Agents Chemother (2000) 1.30
Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group. Clin Infect Dis (1998) 1.24
Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am (2000) 1.21
In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis (2000) 1.19
The biopesticide Paenibacillus popilliae has a vancomycin resistance gene cluster homologous to the enterococcal VanA vancomycin resistance gene cluster. Antimicrob Agents Chemother (2000) 1.10
Quantitative blood cultures in candidemia. Mayo Clin Proc (1991) 1.07
Ketolide treatment of Haemophilus influenzae experimental pneumonia. Antimicrob Agents Chemother (1999) 1.06
Prosthetic joint infection diagnosed postoperatively by intraoperative culture. Clin Orthop Relat Res (2005) 1.04
Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits. Antimicrob Agents Chemother (1992) 1.04
Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis (2010) 1.04
Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc (1999) 1.03
In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis (1998) 1.03
Subarachnoid haemorrhage associated with infectious endocarditis: case report and literature review. Eur J Neurol (2002) 1.01
Prosthetic joint infection due to Mycobacterium tuberculosis: a case series and review of the literature. Am J Orthop (Belle Mead NJ) (1998) 0.98
Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis (1998) 0.98
Mitral stenosis associated with valvular tophi. Mayo Clin Proc (1984) 0.95
Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc (2000) 0.93
Candidemia from a urinary tract source: microbiological aspects and clinical significance. Clin Infect Dis (1993) 0.93
Immunogenicity of three Haemophilus influenzae type b protein conjugate vaccines in HIV seropositive adults and analysis of predictors of vaccine response. Vaccine (1999) 0.92
Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci. Antimicrob Agents Chemother (1992) 0.89
Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus. Antimicrob Agents Chemother (1994) 0.89
Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis. Eur J Clin Microbiol Infect Dis (2005) 0.89
Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis. Antimicrob Agents Chemother (1995) 0.86
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. Antimicrob Agents Chemother (1997) 0.84
DNA sequence resembling vanA and vanB in the vancomycin-resistant biopesticide Bacillus popilliae. J Infect Dis (1998) 0.84
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother (1990) 0.82
The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis. Heart (2008) 0.82
Clinical aspects of antimicrobial resistance. Mayo Clin Proc (2000) 0.81
Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis. Antimicrob Agents Chemother (2001) 0.81
Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis. Antimicrob Agents Chemother (2000) 0.81
Werner Forssmann (1904--1979) and his unusual success story. Mayo Clin Proc (1979) 0.80
Serological investigation of enterococcal infections using western blot. Eur J Clin Microbiol Infect Dis (1996) 0.78
Otologic involvement in late syphilis. Laryngoscope (1984) 0.78
Animal models as predictors of outcome of therapy with broad spectrum cephalosporins. J Antimicrob Chemother (1992) 0.78
Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitis. J Infect Dis (2000) 0.77
Transesophageal echocardiography and bacterial endocarditis. Circulation (1993) 0.75
Editorial response: Orthopedic prosthesis salvage. Clin Infect Dis (1999) 0.75
Infections associated with implantable cardioverter defibrillators--still more questions. Clin Infect Dis (1998) 0.75
Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci. Antimicrob Agents Chemother (1996) 0.75
Evaluation of antibiotic therapy following valve replacement for native valve endocarditis. Eur J Clin Microbiol Infect Dis (2009) 0.75
Psychosocial care of the cardiac transplant patient: a nursing diagnosis approach. Dimens Crit Care Nurs (1990) 0.75
An animal model of pulmonary infection after single lung transplantation. Transplant Proc (1996) 0.75
Tularemia with brain abscesses. Neurology (2007) 0.75
Vertebral osteomyelitis due to Shigella boydii. Clin Infect Dis (1996) 0.75
Infectious Diseases Society of America position statement on the role of hospital pharmacists. Clin Infect Dis (1998) 0.75
Werner Forssmann (1904-1979) and his unusual success story. Conn Med (1981) 0.75
New developments in infective endocarditis. Curr Opin Cardiol (1995) 0.75
69-year-old man with fever, diarrhea, and abdominal pain. Mayo Clin Proc (1998) 0.75
Infectious rates of central venous pressure catheters: comparison between newly placed catheters and those that have been changed. Mayo Clin Proc (1996) 0.75